Arkolith/Insider Trading/SXTP/Form 4

Dow Geoffrey S

President and CEO, Director60 DEGREES PHARMACEUTICALS, INC. (SXTP) · full profile →Form 4 · filed May 21, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 16, 2024Option exercise(M)17K$0.22$4K763K
Apr 12, 2024Option exercise(M)68K$0.27$18K746K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 16, 2024Option exercise(M)17K—$00
Apr 12, 2024Option exercise(M)68K—$017K
Nov 21, 2023Grant(A)85K—$085K

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-045705) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for 60 DEGREES PHARMACEUTICALS, INC.

Build

Ask your agent about SXTP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001213900-24-045705"
Ask your agent
Use Arkolith to summarize insider buying and selling at 60 DEGREES PHARMACEUTICALS, INC.
over the last 90 days and cite the filings.